Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT

• by Otto Simonsson, Melissa Bradley, Joshua C. Black, Karilynn M. Rockhill, Andrew A. Monte, Peter S. Hendricks

• September 29, 2026

The Use of Waivers of Guardian Permission in the United States for Pediatric Digital Health Intervention Research Since 2020: Systematic Review

• by Colleen Stiles-Shields, Elyse Shenberger, Ann Bernica, Gabriella Bobadilla, Kandis Fletcher, Jasmine George, Sydney Gordon, Erika L Gustafson, Crystal S Hernandez, Taylor L Hilderbrand, Sarah N Kumi, Christine A Lee, Sarah I Lorduy, Meera Phanse, Lauren M Potthoff, Naomi Quezada, Dale L Smith, Holly J Hudson, Emily E Anderson

• September 25, 2026

VA/DoD guideline broadens tobacco treatment

Recommendations prioritize varenicline and combination NRT while extending pharmacotherapy to patients not ready to quit.

• by Andrea Surnit

• September 28, 2026

• 5 min

Enhancing the utility of exploratory ‘factors associated with’ studies in global mental health: the importance of context in Sub-Saharan Africa

• by Joan Abaatyo, Wilber Ssembajjwe, Emmanuel Kiiza Mwesiga

• September 27, 2026